- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02289859
Undermining During Cutaneous Wound Closure
July 17, 2017 updated by: University of California, Davis
Undermining During Cutaneous Wound Closure: a Randomized Split Wound Comparative Effectiveness Trial
The purpose of this study is to determine whether undermining during cutaneous surgery improves scar cosmesis compared to wound closure without undermining.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to determine whether undermining during cutaneous surgery improves scar cosmesis compared to wound closure without undermining.
Our aims are to compare outcomes using a split wound model, where half the wound is undermined and the other half is not.
This will be measured via the physician observer scar assessment scale, a validated scar instrument and via wound width.
Our hypothesis is that wound undermining will result in cosmetically superior wound outcomes.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Able to give informed consent themselves
- Patient scheduled for cutaneous surgical procedure with predicted linear closure
- Willing to return for follow up visits
Exclusion Criteria:
- Mentally handicapped
- Incarceration
- Pregnant Women
- Wounds with predicted closure length less than 3 cm
- Wounds with diameter > 3 cm
- Wounds unable to be fully closed without undermining
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Wound Closure with Undermining
The side assigned to undermining will have undermining performed prior to wound closure in the subcutaneous plane.
The amount of undermining will range from 1 cm for wounds with low tension to 2 cm for those with moderate tension.
Since wound diameter will be 3 cm or less and exclude the scalp, high tension wounds are not anticipated.
|
The side assigned to undermining will have undermining performed prior to wound closure in the subcutaneous plane.
The amount of undermining will range from 1 cm for wounds with low tension to 2 cm for those with moderate tension.
Since wound diameter will be 3 cm or less and exclude the scalp, high tension wounds are not anticipated.
One side of the wound will remain un-undermined.
|
|
Active Comparator: Wound Closure without Undermining
One side of the wound will remain un-undermined.
|
The side assigned to undermining will have undermining performed prior to wound closure in the subcutaneous plane.
The amount of undermining will range from 1 cm for wounds with low tension to 2 cm for those with moderate tension.
Since wound diameter will be 3 cm or less and exclude the scalp, high tension wounds are not anticipated.
One side of the wound will remain un-undermined.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of Scar on the Patient and Observer Scar Assessment Scale
Time Frame: 3 months
|
After surgical procedure, half of the subject's wound will be closed after undermining, while the other half is closed without undermining.
After 3 months, subjects will return to clinic for evaluation of the cosmesis of both types of closure techniques.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of Scar Width
Time Frame: 3 months
|
The width of the scar will be measured 1 centimeter from the midline on both sides.
There is no defined width that is considered satisfactory or not satisfactory.
The measurements will be compared between subjects.
|
3 months
|
|
Assessment of Complications
Time Frame: 3 months
|
Noting the presence or absence of bleeding, dehiscence, infection or spitting sutures.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2014
Primary Completion (Actual)
April 1, 2016
Study Completion (Actual)
July 1, 2016
Study Registration Dates
First Submitted
November 10, 2014
First Submitted That Met QC Criteria
November 12, 2014
First Posted (Estimate)
November 13, 2014
Study Record Updates
Last Update Posted (Actual)
July 18, 2017
Last Update Submitted That Met QC Criteria
July 17, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 613430
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound Closure Techniques
-
University of California, DavisCompletedWound Closure Techniques
-
University of California, DavisCompletedUse of 2-octylcyanoacrylate (Dermabond) Versus 5-0 Fast Absorbing Gut During Cutaneous Wound ClosureWound Closure Techniques
-
University of California, DavisCompleted
-
University of California, DavisCompletedWound Closure Techniques
-
Dow University of Health SciencesActive, not recruitingSurgical Wound Infection | Surgical Wound Dehiscence | Wound Closure Techniques | Suture Techniques | Laparotomy/Standerds | Incisional Hernia/Prevention and ControlPakistan
-
Başakşehir Çam & Sakura City HospitalRecruitingBody Image | Gynecologic Cancers | Surgical Wound Closure TechniquesTurkey (Türkiye)
-
Estar Medical dba Medical Technologies, LTDGlobal Clinical Research InstituteNot yet recruitingWound Closure | Wound Chronic DrainingUnited States
-
Assiut UniversityNot yet recruitingPediatric Surgery | Wound Closure Technique | Stoma Reversal Procedure | Purse-String Suture | Conventional Wound Closure
-
Foundation for Southwest Orthopedic ResearchCompletedWound Closure | Total Knee Replacement ClosureUnited States
Clinical Trials on Wound Closure with Undermining
-
University of California, DavisCompletedWound Closure Techniques
-
University of California, DavisCompletedUse of 2-octylcyanoacrylate (Dermabond) Versus 5-0 Fast Absorbing Gut During Cutaneous Wound ClosureWound Closure Techniques
-
Seoul National University Bundang HospitalRecruitingSurgical Site Infection | Wound HealKorea, Republic of
-
Shanghai Ninth People's Hospital Affiliated to...RecruitingTooth Decay | Tooth FractureChina
-
Turku University HospitalCompletedSurgical Wound InfectionFinland
-
Santa Barbara Cottage HospitalCompleted
-
University of Kansas Medical CenterWithdrawnSurgery | Skin Cancer | Suture; Complications, Infection or InflammationUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedSurgical IncisionUnited States
-
Melaka Manipal Medical CollegeCompleted
-
Rigshospitalet, DenmarkEthicon, Inc.CompletedMetastatic Bone Disease of the Proximal FemurDenmark